Aurobindo Pharma

BSE : 524804 | NSE : AUROPHARMA
Industry : Pharmaceuticals | ISIN : INE406A01037 | FreeFloat : 47.89% | FnO : Yes | LotSize : 750
Intellectual Capital (IC)19,691.90
Net Worth (NW)23,953.67
Intrinsic Worth (IW)43,645.57
Market Cap (MC)43,028.40
Economic Value Added-368.76
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)45.12%
IC Gross Margin (EBITDA/IC)27.20%
IC Net Margin (NPT/IC)15.61%
Knowledge Turnover (Sales/IC)1.23
Market to Intrinsic Value (MC/IW)0.99
As OfIntrinsic ValueMarket Price
31 Dec 2021Rs. 744.88Rs. 734.35
26 May 2022 ---- Rs. 535.85
12.75     2.38%
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : NoSell10 DMA : Rs. 544.60AccumulateSell on Rallies
KB > 50% : No50 DMA : Rs. 637.19
0 < M2IV < 1 : YesVol-Price trend : Rising

Question 3 - Is this stock undervalued?

Question 2 - Does this business have significant knowledge assets?

Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.
Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Mar-19
C
5292.20
5324.47
1053.04
866.42
816.34
585.22
528.36
Jun-19
C
5444.60
5460.38
1154.19
913.33
863.44
635.68
645.76
Sep-19
C
5600.47
5621.09
1148.15
904.84
863.90
639.53
656.60
Dec-19
C
5895.00
5925.93
1225.41
975.28
938.17
705.31
816.53
Mar-20
C
6158.43
6191.02
1341.75
1109.34
1077.51
848.99
997.73
Jun-20
C
3419.70
3545.28
1090.41
970.62
960.19
714.68
711.55
Sep-20
C
6483.44
6537.19
1466.03
1208.69
1192.98
805.65
762.79
Dec-20
C
6364.91
6498.31
1487.52
1211.00
1191.51
876.46
950.86
Mar-21
C
6001.50
6079.60
1345.09
1079.09
1060.87
801.18
719.81
Jun-21
C
5701.98
5811.88
1310.28
1030.59
1017.71
769.97
989.99
Sep-21
C
5941.92
6038.50
1272.25
978.04
967.62
696.71
581.43
Dec-21
C
5989.43
6002.22
1108.96
809.91
793.78
604.29
537.19
* C - Consolidated, S - Standalone